_id
6911c357ccc777a4e85d6462
Ticker
HCWB
Name
HCW Biologics Inc
Exchange
NASDAQ
Address
2929 North Commerce Parkway, Miramar, FL, United States, 33025
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.hcwbiologics.com
Description
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201 and HCW9206, novel immunotherapeutic for memory-like natural killer cells, cancer, and pathogens; HCW11-006, an immune cell stimulator; HCW11-002 and HCW11-0027, which are immune checkpoint inhibitors to treat oncology and other senescence-associated indications; and HCW11-018, a fusions and immune cell engagers to treat cancer. The company has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.
Last Close
1.866
Volume
30063
Current Price
1.79
Change
-4.072883172561633
Last Updated
2025-12-01T08:44:15.544Z
Image
data:image/webp;base64,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
Ipo Date
2021-07-20T00:00:00.000Z
Market Cap
5357501
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9860000000000001
Sentiment Sources
3
Rating
4
Target Price
35
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
15606
Cost Of Revenue
186390
Gross Profit
-170784
Operating Expenses
3115336
Operating Income
-3286120
Interest Expense
127070
Pretax Income
-4554336
Net Income
-4554336
Eps
-2.0151322880550495
Dividends Per Share
-
Shares Outstanding
2151607
Income Tax Expense
-
EBITDA
-4253361
Operating Margin
-21056.77303601179
Total Other Income Expense Net
-1268216
Cash
1096909
Short Term Investments
-
Receivables
30667
Inventories
-
Total Current Assets
1588577
Property Plant Equipment
22502158
Total Assets
25445540
Payables
18968173
Short Term Debt
6807431
Long Term Debt
-
Total Liabilities
27552737
Equity
-2107197
Depreciation
173905
Change In Working Capital
-213432
Cash From Operations
-3239941
Capital Expenditures
1
Cash From Investing
-
Cash From Financing
1897888
Net Change In Cash
-1342053
PE
-
PB
-1.9413102239610251
ROE
216.13242615664316
ROA
-17.898366472081157
FCF
-3239942
Fcf Percent
-207.6087402281174
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
1
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
4.5
Growth Investing Score
4.5
Momentum Investing Score
5
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
15606
Quarters > 0 > income Statement > cost Of Revenue
186390
Quarters > 0 > income Statement > gross Profit
-170784
Quarters > 0 > income Statement > operating Expenses
3115336
Quarters > 0 > income Statement > operating Income
-3286120
Quarters > 0 > income Statement > interest Expense
127070
Quarters > 0 > income Statement > pretax Income
-4554336
Quarters > 0 > income Statement > net Income
-4554336
Quarters > 0 > income Statement > eps
-2.0151322880550495
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2260068
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4253361
Quarters > 0 > income Statement > operating Margin
-21056.77303601179
Quarters > 0 > income Statement > total Other Income Expense Net
-1268216
Quarters > 0 > balance Sheet > cash
1096909
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
30667
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1588577
Quarters > 0 > balance Sheet > property Plant Equipment
22502158
Quarters > 0 > balance Sheet > total Assets
25445540
Quarters > 0 > balance Sheet > payables
18968173
Quarters > 0 > balance Sheet > short Term Debt
6807431
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
27552737
Quarters > 0 > balance Sheet > equity
-2107197
Quarters > 0 > cash Flow > net Income
-4554336
Quarters > 0 > cash Flow > depreciation
173905
Quarters > 0 > cash Flow > change In Working Capital
-213432
Quarters > 0 > cash Flow > cash From Operations
-3239941
Quarters > 0 > cash Flow > capital Expenditures
1
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
1897888
Quarters > 0 > cash Flow > net Change In Cash
-1342053
Quarters > 0 > ratios > PE
-2.0151322880550495
Quarters > 0 > ratios > PB
-1.9413102239610251
Quarters > 0 > ratios > ROE
216.13242615664316
Quarters > 0 > ratios > ROA
-17.898366472081157
Quarters > 0 > ratios > FCF
-3239942
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-207.6087402281174
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
6550
Quarters > 1 > income Statement > cost Of Revenue
5240
Quarters > 1 > income Statement > gross Profit
1310
Quarters > 1 > income Statement > operating Expenses
3465387
Quarters > 1 > income Statement > operating Income
-3464077
Quarters > 1 > income Statement > interest Expense
228714
Quarters > 1 > income Statement > pretax Income
-1927730
Quarters > 1 > income Statement > net Income
-1927730
Quarters > 1 > income Statement > eps
-1.082925634496237
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1780113
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1304852
Quarters > 1 > income Statement > operating Margin
-52886.6717557252
Quarters > 1 > income Statement > total Other Income Expense Net
1536347
Quarters > 1 > balance Sheet > cash
2438962
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
21611
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
2897125
Quarters > 1 > balance Sheet > property Plant Equipment
22635596
Quarters > 1 > balance Sheet > total Assets
28909636
Quarters > 1 > balance Sheet > payables
19354476
Quarters > 1 > balance Sheet > short Term Debt
6421204
Quarters > 1 > balance Sheet > long Term Debt
367151
Quarters > 1 > balance Sheet > total Liabilities
28961608
Quarters > 1 > balance Sheet > equity
-51972
Quarters > 1 > cash Flow > net Income
-1927731
Quarters > 1 > cash Flow > depreciation
291916
Quarters > 1 > cash Flow > change In Working Capital
-44973
Quarters > 1 > cash Flow > cash From Operations
-3282303
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
4613652
Quarters > 1 > cash Flow > net Change In Cash
1331349
Quarters > 1 > ratios > PE
-1.082925634496237
Quarters > 1 > ratios > PB
-61.99500750404064
Quarters > 1 > ratios > ROE
3709.170322481336
Quarters > 1 > ratios > ROA
-6.668122697912904
Quarters > 1 > ratios > FCF
-3282303
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-501.11496183206106
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
5065
Quarters > 2 > income Statement > cost Of Revenue
4052
Quarters > 2 > income Statement > gross Profit
1013
Quarters > 2 > income Statement > operating Expenses
1966815
Quarters > 2 > income Statement > operating Income
-1965802
Quarters > 2 > income Statement > interest Expense
255822
Quarters > 2 > income Statement > pretax Income
-2196875
Quarters > 2 > income Statement > net Income
-2196875
Quarters > 2 > income Statement > eps
-0.04917387223144524
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
44675656
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1248984
Quarters > 2 > income Statement > operating Margin
-38811.4906219151
Quarters > 2 > income Statement > total Other Income Expense Net
-231073
Quarters > 2 > balance Sheet > cash
1107613
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
87493
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1894708
Quarters > 2 > balance Sheet > property Plant Equipment
22762471
Quarters > 2 > balance Sheet > total Assets
26285406
Quarters > 2 > balance Sheet > payables
19734057
Quarters > 2 > balance Sheet > short Term Debt
6234338
Quarters > 2 > balance Sheet > long Term Debt
7705364
Quarters > 2 > balance Sheet > total Liabilities
34847454
Quarters > 2 > balance Sheet > equity
-8562048
Quarters > 2 > cash Flow > net Income
-2196875
Quarters > 2 > cash Flow > depreciation
419010
Quarters > 2 > cash Flow > change In Working Capital
-2161633
Quarters > 2 > cash Flow > cash From Operations
-3513856
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-53103
Quarters > 2 > cash Flow > net Change In Cash
-3566959
Quarters > 2 > ratios > PE
-0.04917387223144524
Quarters > 2 > ratios > PB
-9.444345250108386
Quarters > 2 > ratios > ROE
25.658288764557263
Quarters > 2 > ratios > ROA
-8.357774652596198
Quarters > 2 > ratios > FCF
-3513860
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-693.7532082922014
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
394804
Quarters > 3 > income Statement > cost Of Revenue
315843
Quarters > 3 > income Statement > gross Profit
78961
Quarters > 3 > income Statement > operating Expenses
3238719
Quarters > 3 > income Statement > operating Income
-3159758
Quarters > 3 > income Statement > interest Expense
248108
Quarters > 3 > income Statement > pretax Income
-3373273
Quarters > 3 > income Statement > net Income
-3373273
Quarters > 3 > income Statement > eps
-0.08695567331214087
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
38793018
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1915354
Quarters > 3 > income Statement > operating Margin
-800.3358628585323
Quarters > 3 > income Statement > total Other Income Expense Net
-213515
Quarters > 3 > balance Sheet > cash
4674572
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
582201
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5698482
Quarters > 3 > balance Sheet > property Plant Equipment
22909869
Quarters > 3 > balance Sheet > total Assets
30236578
Quarters > 3 > balance Sheet > payables
22332261
Quarters > 3 > balance Sheet > short Term Debt
6314684
Quarters > 3 > balance Sheet > long Term Debt
7377865
Quarters > 3 > balance Sheet > total Liabilities
37006750
Quarters > 3 > balance Sheet > equity
-6770172
Quarters > 3 > cash Flow > net Income
-3373273
Quarters > 3 > cash Flow > depreciation
682507
Quarters > 3 > cash Flow > change In Working Capital
-436186
Quarters > 3 > cash Flow > cash From Operations
-2834881
Quarters > 3 > cash Flow > capital Expenditures
113412
Quarters > 3 > cash Flow > cash From Investing
-113412
Quarters > 3 > cash Flow > cash From Financing
6624644
Quarters > 3 > cash Flow > net Change In Cash
3676351
Quarters > 3 > ratios > PE
-0.08695567331214087
Quarters > 3 > ratios > PB
-10.371281937888728
Quarters > 3 > ratios > ROE
49.8255140342077
Quarters > 3 > ratios > ROA
-11.156265765259548
Quarters > 3 > ratios > FCF
-2948293
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-7.467738422103119
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2566792
Annuals > 0 > income Statement > cost Of Revenue
1607389
Annuals > 0 > income Statement > gross Profit
959403
Annuals > 0 > income Statement > operating Expenses
30439070
Annuals > 0 > income Statement > operating Income
-29479667
Annuals > 0 > income Statement > interest Expense
1158441
Annuals > 0 > income Statement > pretax Income
-30023814
Annuals > 0 > income Statement > net Income
-30023814
Annuals > 0 > income Statement > eps
-0.7739489100847993
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
38793018
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-27680984
Annuals > 0 > income Statement > operating Margin
-1148.5023718322327
Annuals > 0 > income Statement > total Other Income Expense Net
-544147
Annuals > 0 > balance Sheet > cash
4674572
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
582201
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5698482
Annuals > 0 > balance Sheet > property Plant Equipment
22909869
Annuals > 0 > balance Sheet > total Assets
30236578
Annuals > 0 > balance Sheet > payables
22332261
Annuals > 0 > balance Sheet > short Term Debt
6314684
Annuals > 0 > balance Sheet > long Term Debt
7377865
Annuals > 0 > balance Sheet > total Liabilities
37006750
Annuals > 0 > balance Sheet > equity
-6770172
Annuals > 0 > cash Flow > net Income
-30023814
Annuals > 0 > cash Flow > depreciation
1184389
Annuals > 0 > cash Flow > change In Working Capital
13603404
Annuals > 0 > cash Flow > cash From Operations
-14227428
Annuals > 0 > cash Flow > capital Expenditures
261617
Annuals > 0 > cash Flow > cash From Investing
-261617
Annuals > 0 > cash Flow > cash From Financing
15568516
Annuals > 0 > cash Flow > net Change In Cash
1079471
Annuals > 0 > ratios > PE
-0.7739489100847993
Annuals > 0 > ratios > PB
-12.147578844377957
Annuals > 0 > ratios > ROE
443.471953149787
Annuals > 0 > ratios > ROA
-99.29633571629701
Annuals > 0 > ratios > FCF
-14489045
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-5.644806825017376
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2841794
Annuals > 1 > income Statement > cost Of Revenue
2281434
Annuals > 1 > income Statement > gross Profit
560360
Annuals > 1 > income Statement > operating Expenses
26277520
Annuals > 1 > income Statement > operating Income
-25717160
Annuals > 1 > income Statement > interest Expense
283042
Annuals > 1 > income Statement > pretax Income
-24994277
Annuals > 1 > income Statement > net Income
-24994277
Annuals > 1 > income Statement > eps
-0.6956488279835987
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
35929446
Annuals > 1 > income Statement > income Tax Expense
-4
Annuals > 1 > income Statement > EBITDA
-23576051
Annuals > 1 > income Statement > operating Margin
-904.9621471507082
Annuals > 1 > income Statement > total Other Income Expense Net
722883
Annuals > 1 > balance Sheet > cash
3595101
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
1535757
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
6404187
Annuals > 1 > balance Sheet > property Plant Equipment
20453184
Annuals > 1 > balance Sheet > total Assets
28513660
Annuals > 1 > balance Sheet > payables
6167223
Annuals > 1 > balance Sheet > short Term Debt
28500
Annuals > 1 > balance Sheet > long Term Debt
6304318
Annuals > 1 > balance Sheet > total Liabilities
15051943
Annuals > 1 > balance Sheet > equity
13461717
Annuals > 1 > cash Flow > net Income
-24994277
Annuals > 1 > cash Flow > depreciation
1135184
Annuals > 1 > cash Flow > change In Working Capital
-4643036
Annuals > 1 > cash Flow > cash From Operations
-22514121
Annuals > 1 > cash Flow > capital Expenditures
6202600
Annuals > 1 > cash Flow > cash From Investing
3797400
Annuals > 1 > cash Flow > cash From Financing
-14534
Annuals > 1 > cash Flow > net Change In Cash
-18731255
Annuals > 1 > ratios > PE
-0.6956488279835987
Annuals > 1 > ratios > PB
5.658299421983095
Annuals > 1 > ratios > ROE
-185.66930949447234
Annuals > 1 > ratios > ROA
-87.65720359995875
Annuals > 1 > ratios > FCF
-28716721
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-10.10513816272397
Annuals > 1 > health Score
19
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
6722090
Annuals > 2 > income Statement > cost Of Revenue
4135712
Annuals > 2 > income Statement > gross Profit
2586378
Annuals > 2 > income Statement > operating Expenses
17665156
Annuals > 2 > income Statement > operating Income
-15078778
Annuals > 2 > income Statement > interest Expense
126660
Annuals > 2 > income Statement > pretax Income
-14900703
Annuals > 2 > income Statement > net Income
-14900703
Annuals > 2 > income Statement > eps
-0.41596224179001157
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
35822249
Annuals > 2 > income Statement > income Tax Expense
-178075
Annuals > 2 > income Statement > EBITDA
-14056189
Annuals > 2 > income Statement > operating Margin
-224.31681218192554
Annuals > 2 > income Statement > total Other Income Expense Net
178075
Annuals > 2 > balance Sheet > cash
22326356
Annuals > 2 > balance Sheet > short Term Investments
9735930
Annuals > 2 > balance Sheet > receivables
417695
Annuals > 2 > balance Sheet > inventories
1394923
Annuals > 2 > balance Sheet > total Current Assets
34070919
Annuals > 2 > balance Sheet > property Plant Equipment
10804610
Annuals > 2 > balance Sheet > total Assets
46809155
Annuals > 2 > balance Sheet > payables
1226156
Annuals > 2 > balance Sheet > short Term Debt
6409893
Annuals > 2 > balance Sheet > long Term Debt
6409893
Annuals > 2 > balance Sheet > total Liabilities
9380649
Annuals > 2 > balance Sheet > equity
37428506
Annuals > 2 > cash Flow > net Income
-14900703
Annuals > 2 > cash Flow > depreciation
717854
Annuals > 2 > cash Flow > change In Working Capital
2488089
Annuals > 2 > cash Flow > cash From Operations
-10386110
Annuals > 2 > cash Flow > capital Expenditures
10275128
Annuals > 2 > cash Flow > cash From Investing
14708392
Annuals > 2 > cash Flow > cash From Financing
6273397
Annuals > 2 > cash Flow > net Change In Cash
10595679
Annuals > 2 > ratios > PE
-0.41596224179001157
Annuals > 2 > ratios > PB
2.029019482637111
Annuals > 2 > ratios > ROE
-39.81110814308217
Annuals > 2 > ratios > ROA
-31.832881836897077
Annuals > 2 > ratios > FCF
-20661238
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.073633051625313
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
4099750
Annuals > 3 > income Statement > cost Of Revenue
543598
Annuals > 3 > income Statement > gross Profit
-543598
Annuals > 3 > income Statement > operating Expenses
12824236
Annuals > 3 > income Statement > operating Income
-13367834
Annuals > 3 > income Statement > interest Expense
505366
Annuals > 3 > income Statement > pretax Income
-12862468
Annuals > 3 > income Statement > net Income
-12862468
Annuals > 3 > income Statement > eps
-0.35960559897455463
Annuals > 3 > income Statement > dividends Per Share
2822081
Annuals > 3 > income Statement > shares Outstanding
35768264
Annuals > 3 > income Statement > income Tax Expense
-505366
Annuals > 3 > income Statement > EBITDA
-12318865
Annuals > 3 > income Statement > operating Margin
-326.06461369595706
Annuals > 3 > income Statement > total Other Income Expense Net
505366
Annuals > 3 > balance Sheet > cash
11730677
Annuals > 3 > balance Sheet > short Term Investments
24983520
Annuals > 3 > balance Sheet > receivables
133000
Annuals > 3 > balance Sheet > inventories
2196557
Annuals > 3 > balance Sheet > total Current Assets
40480371
Annuals > 3 > balance Sheet > property Plant Equipment
1119090
Annuals > 3 > balance Sheet > total Assets
53514829
Annuals > 3 > balance Sheet > payables
223664
Annuals > 3 > balance Sheet > short Term Debt
1800000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2321589
Annuals > 3 > balance Sheet > equity
51193240
Annuals > 3 > cash Flow > net Income
-12862468
Annuals > 3 > cash Flow > depreciation
543598
Annuals > 3 > cash Flow > change In Working Capital
1455401
Annuals > 3 > cash Flow > cash From Operations
-10975717
Annuals > 3 > cash Flow > capital Expenditures
47263
Annuals > 3 > cash Flow > cash From Investing
-35018915
Annuals > 3 > cash Flow > cash From Financing
49269475
Annuals > 3 > cash Flow > net Change In Cash
3274843
Annuals > 3 > ratios > PE
-0.35960559897455463
Annuals > 3 > ratios > PB
1.481225249271193
Annuals > 3 > ratios > ROE
-25.12532514058497
Annuals > 3 > ratios > ROA
-24.035334206150598
Annuals > 3 > ratios > FCF
-11022980
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.688695652173913
Annuals > 3 > health Score
34
Valuation > metrics > PE
-2.0151322880550495
Valuation > metrics > PB
-1.9413102239610251
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
216.13242615664316
Profitability > metrics > ROA
-286.692807462276
Profitability > metrics > Net Margin
-291.8323721645521
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-25.860706697096088
Risk > final Score
-73
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.06163102909247054
Liquidity > metrics > Quick Ratio
0.06163102909247054
Liquidity > final Score
13
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-31
Prev Risks > 1
-1
Prev Risks > 2
-21
Prev Liquidities > 0
16
Prev Liquidities > 1
14
Prev Liquidities > 2
20
Updated At
2025-12-16T15:36:19.928Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-17
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-2.0151
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-18
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-6.79
Earnings History > 1 > eps Estimate
1.8
Earnings History > 1 > eps Difference
-8.59
Earnings History > 1 > surprise Percent
-477.2222
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.97
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-28
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-3.2
Earnings History > 3 > eps Estimate
3.6
Earnings History > 3 > eps Difference
-6.8
Earnings History > 3 > surprise Percent
-188.8889
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-4
Earnings History > 4 > eps Estimate
-5.2
Earnings History > 4 > eps Difference
1.2
Earnings History > 4 > surprise Percent
23.0769
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-20
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.18
Earnings History > 5 > eps Estimate
-0.18
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.3
Earnings History > 6 > eps Estimate
-0.14
Earnings History > 6 > eps Difference
-0.16
Earnings History > 6 > surprise Percent
-114.2857
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-26
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.3
Earnings History > 7 > eps Estimate
-0.145
Earnings History > 7 > eps Difference
-0.155
Earnings History > 7 > surprise Percent
-106.8966
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.14
Earnings History > 8 > eps Estimate
-0.13
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-7.6923
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-11
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.12
Earnings History > 9 > eps Estimate
-0.15
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
20
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-09
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.14
Earnings History > 10 > eps Estimate
-0.14
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-28
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.15
Earnings History > 11 > eps Estimate
-0.16
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
6.25
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-07
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.11
Earnings History > 12 > eps Estimate
-0.12
Earnings History > 12 > eps Difference
0.01
Earnings History > 12 > surprise Percent
8.3333
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.1
Earnings History > 13 > eps Estimate
-0.12
Earnings History > 13 > eps Difference
0.02
Earnings History > 13 > surprise Percent
16.6667
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.06
Earnings History > 14 > eps Estimate
-0.11
Earnings History > 14 > eps Difference
0.05
Earnings History > 14 > surprise Percent
45.4545
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-29
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.17
Earnings History > 15 > eps Estimate
-0.12
Earnings History > 15 > eps Difference
-0.05
Earnings History > 15 > surprise Percent
-41.6667
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.08
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.2
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.2
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-30
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.657
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.657
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.6862
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.6862
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-06-30
Earnings History > 20 > report Date
2020-09-30
Earnings History > 20 > date
2020-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.6307
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.6307
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-03-31
Earnings History > 21 > report Date
2020-06-30
Earnings History > 21 > date
2020-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.6472
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.6472
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-12-31
Earnings History > 22 > report Date
2020-03-31
Earnings History > 22 > date
2019-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.5629
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.5629
Earnings History > 22 > surprise Percent
-
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201 and HCW9206, novel immunotherapeutic for memory-like natural killer cells, cancer, and pathogens; HCW11-006, an immune cell stimulator; HCW11-002 and HCW11-0027, which are immune checkpoint inhibitors to treat oncology and other senescence-associated indications; and HCW11-018, a fusions and immune cell engagers to treat cancer. The company has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInsiders' US$3.05m Investments In Red Following HCW Biologics' US$1.1m Dip In Market Value simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$35
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 1.72% of the total shares of HCW Biologics Inc
1.
Golden State Wealth Management, LLC(0.4648%)
since
2025/06/30
2.
UBS Group AG(0.4424%)
since
2025/06/30
3.
Fidelity Extended Market Index(0.2698%)
since
2025/07/31
4.
Vanguard Institutional Extnd Mkt Idx Tr(0.1941%)
since
2025/07/31
5.
Spartan Extended Market Index Pool F(0.0888%)
since
2025/07/31
6.
Wells Fargo & Co(0.079%)
since
2025/06/30
7.
Fidelity Series Total Market Index(0.044%)
since
2025/07/31
8.
Fidelity Total Market Index(0.0337%)
since
2025/07/31
9.
Spartan Total Market Index Pool G(0.029%)
since
2025/07/31
10.
Fidelity Nasdaq Composite Index(0.0191%)
since
2025/07/31
11.
Tower Research Capital LLC(0.0116%)
since
2025/06/30
12.
Northern Trust Extended Eq Market Idx(0.0106%)
since
2025/06/30
13.
NT Ext Equity Mkt Idx Fd - L(0.0106%)
since
2025/06/30
14.
ZWJ Balanced(0.0037%)
since
2025/06/30
15.
State St US Extended Mkt Indx NL Cl C(0.0035%)
since
2025/08/31
16.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.003%)
since
2025/06/30
17.
Fortitude Family Office LLC(0.0027%)
since
2025/06/30
18.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0025%)
since
2024/12/31
19.
SSgA U.S. Total Market Index Strategy(0.0015%)
since
2025/03/31
20.
Northern Trust Wilshire 5000(0.0013%)
since
2025/06/30
21.
Advisor Group Holdings, Inc.(0.0012%)
since
2025/06/30
22.
State St US Ttl Mkt Indx NL Cl A(0.0011%)
since
2025/08/31
23.
Bank of America Corp(0.0005%)
since
2025/06/30
24.
SBI Securities Co Ltd(0.0003%)
since
2025/06/30
25.
Fidelity U.S. Equity Index Ins Trust(0.0002%)
since
2025/07/31
26.
State Street Corp(0%)
since
2025/06/30
27.
BlackRock Inc(0%)
since
2025/06/30
28.
Northern Trust Corp(0%)
since
2025/06/30
29.
Bridgeway Capital Management, LLC(0%)
since
2025/03/31
30.
JustInvest LLC(0%)
since
2025/06/30
31.
Two Sigma Investments LLC(0%)
since
2025/03/31
32.
Virtu Financial LLC(0%)
since
2025/03/31
33.
XTX Topco Ltd(0%)
since
2025/03/31
34.
AE Wealth Management LLC(0%)
since
2025/06/30
35.
J.W. COLE ADVISORS, INC.(0%)
since
2025/06/30
36.
HighTower Advisors, LLC(0%)
since
2025/03/31
37.
Cresset Asset Management, LLC(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.0151
EPS Estimate
—
EPS Difference
0
Surprise Percent
null%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.